1-3 of 3
Stefano Di Cecca, PhD
Close
Sort by
Journal Articles

A New Promising Third Generation CAR-CD30 T-Cell Therapy for CD30+ Lymphoma

Biagio De Angelis, PhD, Marika Guercio, Domenico Orlando, PhD, Stefano Di Cecca, PhD, Matilde Sinibaldi, PhD, Iolanda Boffa, PhDstudent, Simona Caruso, PhD, Zeinab Abbaszadeh, Antonio Camera, PhDStudent, Cembrola Biancamaria, PhD, Katia Bovetti, Ignazio Caruana, PhD, Francesca Del Bufalo, MD, Pietro Merli, MD, Luciana Vinti, MD, Katia Girardi, MD, Annalisa Ruggeri, MD, Rita De Vito, MD, Concetta Quintarelli, PhD, Franco Locatelli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2069.
https://doi.org/10.1182/blood-2019-127969
Published: 2019
Journal Articles

CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells

Concetta Quintarelli, PhD, Simona Sivori, PhD, Simona Caruso, PhD, Simona Carlomagno, PhD, Iolanda Boffa, PhDstudent, Domenico Orlando, PhDstudent, Marika Guercio, Biancamaria Cembrola, PhD, Angela Pitisci, Stefano Di Cecca, PhD, Giuseppina Li Pira, PhD, Luciana Vinti, MD, Biagio De Angelis, PhD, Lorenzo Moretta, MD PhD, Franco Locatelli
Journal: Blood
Blood (2018) 132 (Supplement 1): 3491.
https://doi.org/10.1182/blood-2018-99-118005
Published: 2018
Journal Articles

Patient-Derived Chimeric Antigen Receptor T-Cell Production Based on a Gammaretroviral Vector Platform Is Not Associated with Generation of CAR+ Leukemia Blasts

Concetta Quintarelli, PhD, Iolanda Boffa, PhDstudent, Matilde Sinibaldi, Domenico Orlando, PhDstudent, Marika Guercio, Stefano Di Cecca, PhD, Simona Caruso, PhD, Angela Pitisci, Valentina Bertaina, Francesca Del Bufalo, MD, Pietro Merli, MD, Mattia Algeri, MD, Federica Galaverna, MD, Luciana Vinti, MD, Giuseppina Li Pira, PhD, Biagio De Angelis, PhD, Franco Locatelli
Journal: Blood
Blood (2018) 132 (Supplement 1): 2204.
https://doi.org/10.1182/blood-2018-99-119413
Published: 2018